Cargando…

Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy

Ischemic stroke causes acute CNS injury and long-term disability, with limited treatment options such as surgical clot removal or clot-busting drugs. Neuroprotective therapies are needed to protect vulnerable brain regions. The purinergic receptor P2X4 is activated during stroke and exacerbates post...

Descripción completa

Detalles Bibliográficos
Autores principales: Arul, Michael R., Alahmadi, Ibtihal, Turro, Daylin Gamiotea, Ruikar, Aditya, Abdulmalik, Sama, Williams, Justin T., Sanganahalli, Basavaraju G., Liang, Bruce T., Verma, Rajkumar, Kumbar, Sangamesh G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697427/
https://www.ncbi.nlm.nih.gov/pubmed/37902365
http://dx.doi.org/10.1039/d3bm00951c

Ejemplares similares